EndoVention raises $1.5M for clot-removing catheters
San Francisco’s EndoVention, a developer of catheters for use in blood-clot removal, raised $1.5 million of an expected $2.5 million first round, VentureWire reports (subscription required). Such catheters are flexible tubes that doctors can insert into blocked blood vessels in order to “vacuum out” clots, sometimes with the assistances of clot-dissolving drugs. EndoVention’s device has an “expandable mouth” to regulate the intake of clots.
Angel investors provided the funding, EndoVention CEO Peter Yorke told VentureWire.
Next Story: Endovention raises $1.5M for catheters that remove clots
Previous Story: Xing integrates with ZoomInfo, in move to overtake LinkedIn
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.